[Pharmacological studies on niflumic acid, with special reference to the comparison with fenametes. 1. Anti-inflammatory and analgesic actions].
D000700:Analgesics; D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000188:drug therapy; D002199:Capillary Permeability / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D005461:Fluorine / Q000494:pharmacology / Q000627:therapeutic use; D006097:Granulation Tissue / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D011489:Protein Denaturation / Q000187:drug effects; D051381:Rats; D014945:Wound Healing / Q000187:drug effects
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D005461:Fluorine; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D010653:Phenylbutazone; D007213:Indomethacin